Disrupting Treatment of Cardiovascular Disease with Epigenetics: Resverlogix CEO Donald McCaffrey October 20, 2015
Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital’s Eden Rahim August 18, 2015
